Akèy › Akidan serebavaskilè › North Carolina › Raleigh
Etid klinik pou Akidan serebavaskilè nan Raleigh, NC
5 etid pou Akidan serebavaskilè ap chèche patisipan nan sit nan ak bò kote Raleigh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
CoMind Early Feasibility Study
Ap rekriteEtid obsèvasyon
- WakeMed, Raleigh
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- Accellacare US Inc, Raleigh
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Ap rekriteFaz 2
- WakeMed, Raleigh
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Ap rekriteFaz 3
- Duke Raleigh Hospital, Raleigh
Stroke Thrombectomy and Aneurysm Registry
Ap rekriteEtid obsèvasyon
- University of North Carolina, Raleigh
Etid Akidan serebavaskilè nan lòt vil
- Chicago, IL34 etid
- New York City, NY30 etid
- Boston, MA30 etid
- Houston, TX24 etid
- Baltimore, MD22 etid
- Pittsburgh, PA22 etid
- Atlanta, GA20 etid
- Charleston, SC18 etid
- Washington, DC18 etid
- Philadelphia, PA18 etid
- Cleveland, OH16 etid
- Jacksonville, FL16 etid
Lòt etid nan Raleigh
- Ensifizyans kadyak7 etid
- Dyabèt Tip 26 etid
- Obèsite6 etid
- Maladi atè koronè6 etid
- Degeneresans makile6 etid
- Kansè Endomèt5 etid
- Sipwa5 etid
- Maladi kadyovaskilè5 etid
- Ateroskleroz5 etid
- Dyabèt4 etid
- Edem makile4 etid
- Kansè Poumon ki pa ti selil4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.